Mr. Cai, aged 63, Chairman and Chief Executive Officer of the Company, was appointed as an executive director of the Company in 1998. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a deputy of the 12th National People's Congress of the People's Republic of China (the "PRC"). Mr. Cai is also a director of True Ally Holdings Limited, Massive Giant Group Limited, Massive Top Limited, March Rise Limited, and the general partner of Beijing Zhongyihe Hezhong Investment Management Centre (Limited Partnership), all of which are substantial shareholders of the Company within the meaning of Part XV of the Securities and Futures Ordinance ("SFO").
pharmaceutical industry